Mumbai, Aug. 26 -- Eris Lifesciencesannounced that one of its sterile injectable manufacturing facilities in Ahmedabad has received approval from Anvisa, Brazil's national health regulatory agency. This facility is part of subsidiary Swiss Parenterals that was acquired by Eris in 2024.

Published by HT Digital Content Services with permission from Capital Market....